 | Catalyst Pharmaceuticals, Inc. | |||
| NCM : CPRX || Location: United States | ||||
$15.1+0.37 (+2.51%) |
0.55 M | 14.74 - 15.18 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 6.054 M |
| March 15, 2024 | 5.825 M |
| Feb. 29, 2024 | 6.467 M |
| Feb. 15, 2024 | 5.675 M |
| Jan. 31, 2024 | 4.686 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.27 | 0.31 | 14.69% |
| 09/30/2023 | -0.29 | -0.29 | 0.24% |
| 06/30/2023 | 0.36 | 0.53 | 45.97% |
| 03/31/2023 | 0.33 | 0.26 | -20.83% |
| 12/31/2022 | 0.22 | 0.22 | 1.76% |
CPRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 118.011M | Shares Float | 101.656M |
| Short Float | 6.054M | Market Cap | 1738.30M |
| Institution ownership | 73.26% | Insider ownership | 6.214% |
| Earnings Date | 05/30/2024 AMC | Cash Per Share | ? |
| Trailing EPS | 0.63 | Forward EPS | 1.41 |